These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 34322760

  • 1. Anti-ANX A1 Antibody Therapy in MRL/lpr Murine Model of Systemic Lupus Erythematosus.
    Bradyanova S, Mihaylova N, Chipinski P, Manassiev Y, Herbáth M, Kyurkchiev D, Prechl J, Tchorbanov AI.
    Arch Immunol Ther Exp (Warsz); 2021 Jul 28; 69(1):19. PubMed ID: 34322760
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal antibody therapy that targets phospholipid-binding protein delays lupus activity in MRL/lpr mice.
    Mihaylova N, Bradyanova S, Chipinski P, Chausheva S, Kyurkchiev D, Tchorbanov AI.
    Scand J Immunol; 2020 Sep 28; 92(3):e12915. PubMed ID: 32533866
    [Abstract] [Full Text] [Related]

  • 3. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N, Bradyanova S, Chipinski P, Herbáth M, Chausheva S, Kyurkchiev D, Prechl J, Tchorbanov AI.
    Autoimmunity; 2017 Jun 28; 50(4):257-268. PubMed ID: 28300427
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 28; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S.
    Mol Immunol; 2013 Dec 28; 56(4):574-82. PubMed ID: 23911415
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C.
    Phytomedicine; 2019 Sep 28; 62():152965. PubMed ID: 31129432
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
    Rohraff DM, He Y, Farkash EA, Schonfeld M, Tsou PS, Sawalha AH.
    Arthritis Rheumatol; 2019 Oct 28; 71(10):1681-1690. PubMed ID: 31106974
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Celastrol ameliorates lupus by promoting apoptosis of autoimmune T cells and preventing autoimmune response in MRL/lpr mice.
    Xie T, Rui H, Liu H, Liu X, Liu X, Li P.
    Lupus Sci Med; 2024 Mar 11; 11(1):. PubMed ID: 38471722
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intermittent Fasting Aggravates Lupus Nephritis through Increasing Survival and Autophagy of Antibody Secreting Cells in MRL/lpr Mice.
    Hong SM, Lee J, Jang SG, Song Y, Kim M, Lee J, Cho ML, Kwok SK, Park SH.
    Int J Mol Sci; 2020 Nov 11; 21(22):. PubMed ID: 33187196
    [Abstract] [Full Text] [Related]

  • 16. Regulation of T cell-dependent autoantibody production by a gammadelta T cell line derived from lupus-prone mice.
    Fujii T, Okada M, Craft J.
    Cell Immunol; 2002 Nov 11; 217(1-2):23-35. PubMed ID: 12425998
    [Abstract] [Full Text] [Related]

  • 17. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 18. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J, Fan H, Li F, Li X, Dong G, Gong W, Song Y, Liu F, Hua C, Tan R, Dou H, Hou Y.
    Immunol Lett; 2015 Dec 15; 168(2):355-65. PubMed ID: 26545567
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of receptor interacting protein kinase-1 (RIPK1) in the treatment of murine lupus.
    Peng L, Wang P, Xu X, Chen D, Xu F, Yang F, Yang S, Xia H, Liu ZH, Qin W.
    Lupus Sci Med; 2024 Jun 21; 11(1):. PubMed ID: 38906550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.